PJC
IDXX icon

Phillip James Consulting’s Idexx Laboratories IDXX Stock Holding History

Phillip James Consulting’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$526 Hold
1
– – ﹤0.01% 312
2026
Q1 		$1K Buy
+1
New +$641 ﹤0.01% 299

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Phillip James Consulting's IDXX Position: Q2 2026 in Review

Phillip James Consulting held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1 share worth $526. The position accounts for ﹤0.01% of the portfolio, ranked #312.

Phillip James Consulting first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1K in Q1 2026. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Phillip James Consulting held 1 share of Idexx Laboratories worth $526 as of Q2 2026.
  • Phillip James Consulting left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Phillip James Consulting's portfolio in Q2 2026, its #312 holding.
  • Phillip James Consulting first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Phillip James Consulting's Idexx Laboratories position peaked at $1K in Q1 2026.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Phillip James Consulting's 13F filing for Q2 2026, filed 28 Jul 2026.